JENNA BAER: Open Payments
NPI 1932979317 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 34 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $165 |
| ABBVIE INC. | 5 | $114 |
| Exact Sciences Corporation | 2 | $50 |
| Amgen Inc. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Lundbeck LLC | 1 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: Wegovy, REXULTI, Cologuard Collection Kit, UBRELVY, QULIPTA, Rybelsus, JARDIANCE, LEQVIO.
Industry payments across PA — which companies pay providers there.
